MYLAN INSTITUTIONAL INC 2898 — Heparin Importer Profile
Pharmaceutical Importer · #7 buyer for Heparin · $3.3M import value · 66 shipments · UNITED STATES · DGFT Verified
MYLAN INSTITUTIONAL INC 2898 is the #7 importer of Heparin from India with $3.3M in import value and 66 verified shipments. MYLAN INSTITUTIONAL INC 2898 holds a 0.8% market share in Heparin imports based in UNITED STATES. The company sources from 1 verified supplier across 57 formulations shipped to 1 country. Overall, MYLAN INSTITUTIONAL INC 2898 imports 11 pharmaceutical products worth $26.8M across 8 therapeutic categories.
MYLAN INSTITUTIONAL INC 2898 — Heparin Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Heparin to MYLAN INSTITUTIONAL INC 2898?
Verified from 66 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| MYLAN LABORATORIES LIMITED | $3.3M | 66 | 100.0% |
MYLAN INSTITUTIONAL INC 2898 sources Heparin from 1 verified Indian supplier based on 66 customs records. The primary supplier is MYLAN LABORATORIES LIMITED accounting for 100.0% of imports.
How Does MYLAN INSTITUTIONAL INC 2898 Compare to Nearest Heparin Importers?
Buyers ranked immediately above and below #7 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 6 | FRESENIUS KABI USA LLC | UNITED STATES | $3.5M | 69 | $50.0K |
| 18 | PHARMACEUTICAL TECHNOLOGY | DOMINICAN REPUBLIC | $3.0M | 64 | $46.4K |
| 7 | MYLAN INSTITUTIONAL INC 2898 ★ | UNITED STATES | $2.9M | 57 | $50.0K |
| 12 | NORDIC PHARMACEUTICAL COMPANY SAC | PERU | $2.7M | 54 | $50.0K |
| 10 | EVERSANA EVERSANA | UNITED STATES | $2.2M | 44 | $50.0K |
MYLAN INSTITUTIONAL INC 2898 ranks #7 among 854 Heparin importers from India. Average shipment value of $50.0K compared to the market average of $80.1K. The closest competitors by value are FRESENIUS KABI USA LLC and PHARMACEUTICAL TECHNOLOGY.
Where Does MYLAN INSTITUTIONAL INC 2898 Import Heparin To?
Destination countries from 66 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $3.3M | 66 | 100.0% |
MYLAN INSTITUTIONAL INC 2898 imports Heparin to 1 country. The primary destination is UNITED STATES receiving 100.0% of shipments worth $3.3M.
What Heparin Formulations Does MYLAN INSTITUTIONAL INC 2898 Import?
| Formulation | Value | Shipments |
|---|---|---|
| HEPARIN SOD INJ 10000U 1ML 25S MYL US 7 | $200.0K | 4 |
| HEPARIN SOD INJ 5000U 10ML 25S MDV MY US | $100.0K | 2 |
| HEPARIN SOD INJ 5000U 1ML 25S MYL US (76 | $100.0K | 2 |
| HEPARIN SOD INJ 1000U 30ML 25S MDV MY US | $100.0K | 2 |
| HEPARIN SOD INJ 5000U 1ML 25S MYL US 76 | $100.0K | 2 |
| HEPARIN SOD INJ 1000U 30ML 25S MDV MY US7608717 TAX VAL 12759997.96 | $100.0K | 2 |
| HEPARIN SOD INJ 1000U 30ML 25S MDV MY US7608754 TAX VAL 12961907.29 | $100.0K | 2 |
| HEPARIN SOD INJ 1000U 10ML 25S MDV MY US | $50.0K | 1 |
| HEPARIN SOD INJ 1000U 1ML 25S MYLUS (760 | $50.0K | 1 |
| Heparin Sod Inj 1000U-10mL-25s-MDV My-US | $50.0K | 1 |
MYLAN INSTITUTIONAL INC 2898 imports 57 distinct Heparin formulations from India. The top formulation is HEPARIN SOD INJ 10000U 1ML 25S MYL US 7 with 4 shipments worth $200.0K.
Regulatory Requirements: Importing Heparin into United States
What MYLAN INSTITUTIONAL INC 2898 and other importers must comply with to import Heparin from India
Regulatory Authority
U.S. Food and Drug Administration (FDA)
Approval Process for Generic Heparin
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10–18 months for ANDA approval
GMP Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
Import Licence & Documentation
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
Labeling & Packaging
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Heparin from India and How Much Does MYLAN INSTITUTIONAL INC 2898 Import?
India exported $68.4M worth of Heparin through 4,586 shipments from 391 suppliers to 137 countries, serving 854 buyers globally. MYLAN INSTITUTIONAL INC 2898 imports $3.3M of this total, accounting for 0.8% of India's Heparin exports with 66 shipments from UNITED STATES. This is verified from 66 customs shipment records covering 57 distinct formulations.
What Is the Average Order Value for MYLAN INSTITUTIONAL INC 2898's Heparin Imports?
MYLAN INSTITUTIONAL INC 2898's average Heparin order value is $50.0K per consignment, based on 66 shipments totaling $3.3M. MYLAN INSTITUTIONAL INC 2898 is based in UNITED STATES and ranks #7 among all Heparin importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Heparin to MYLAN INSTITUTIONAL INC 2898?
MYLAN INSTITUTIONAL INC 2898 sources Heparin from 1 verified Indian supplier: MYLAN LABORATORIES LIMITED ($3.3M, 100.0%). This is based on 66 customs records.
How Does MYLAN INSTITUTIONAL INC 2898 Compare to Other Heparin Importers?
MYLAN INSTITUTIONAL INC 2898 ranks #7 among 854 Heparin importers from India with a 0.8% market share. The top 3 importers are FRESENIUS KABI USA, LLC ($19.4M), EVERSANA ($13.4M), BOSTON ONCOLOGY ARABIA ($11.2M). MYLAN INSTITUTIONAL INC 2898 processed 66 shipments from UNITED STATES.
About MYLAN INSTITUTIONAL INC 2898
MYLAN INSTITUTIONAL INC 2898 imports 11 products worth $26.8M. Beyond Heparin, top products include Vancomycin, Famotidine, Amino, Docetaxel, Dexamethasone. View the complete MYLAN INSTITUTIONAL INC 2898 profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Heparin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Heparin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: MYLAN INSTITUTIONAL INC 2898 matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as MYLAN INSTITUTIONAL INC 2898's capped import value divided by total capped export value for Heparin across all Indian exporters.
- 5.Verified Records: This page is backed by 66 individual customs records matching MYLAN INSTITUTIONAL INC 2898 importing Heparin, covering 57 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 137+ countries, 854+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Heparin Import Data for MYLAN INSTITUTIONAL INC 2898
Access order-level details, pricing data, supplier connections, and competitive analysis for MYLAN INSTITUTIONAL INC 2898's Heparin imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
MYLAN INSTITUTIONAL INC 2898
Full Company Profile →
11 products · $26.8M total trade · 8 categories
MYLAN INSTITUTIONAL INC 2898 × Heparin
Verified from customs records
Company Overview
Top Products by MYLAN INSTITUTIONAL INC 2898
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for MYLAN INSTITUTIONAL INC 2898.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Heparin. For current order-level data, contact TransData Nexus.